Table I.
Group | Sensitize on days 1 and 14 | Challenge on days 21, 22 and 23 | Intratracheal agents |
---|---|---|---|
Control | Saline | Saline | Saline |
OVA | OVA | OVA | Saline |
LY294002 | OVA | OVA | LY294002 |
Akt inhibitor IV | OVA | OVA | Akt inhibitor IV |
OVA, ovalbumin; Akt, protein kinase B.